Donald J. Griffith - Net Worth and Insider Trading

Donald J. Griffith Net Worth

The estimated net worth of Donald J. Griffith is at least $5,681 dollars as of 2024-11-13. Donald J. Griffith is the Director of Outlook Therapeutics Inc and owns about 906 shares of Outlook Therapeutics Inc (OTLK) stock worth over $5,681. Details can be seen in Donald J. Griffith's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Donald J. Griffith has not made any transactions after 2016-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Donald J. Griffith

To

Donald J. Griffith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Donald J. Griffith owns 2 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) , and Outlook Therapeutics Inc (OTLK) .

Click here to see the complete history of Donald J. Griffith’s form 4 insider trades.

Insider Ownership Summary of Donald J. Griffith

Ticker Comapny Transaction Date Type of Owner
SONN Sonnet BioTherapeutics Holdings Inc 2020-04-01 director
OTLK Outlook Therapeutics Inc 2016-11-23 director

Donald J. Griffith Latest Holdings Summary

Donald J. Griffith currently owns a total of 1 stock. Donald J. Griffith owns 906 shares of Outlook Therapeutics Inc (OTLK) as of November 23, 2016, with a value of $5,681.

Latest Holdings of Donald J. Griffith

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OTLK Outlook Therapeutics Inc 2016-11-23 906 6.27 5,681

Holding Weightings of Donald J. Griffith


Donald J. Griffith Form 4 Trading Tracker

According to the SEC Form 4 filings, Donald J. Griffith has made a total of 0 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years. The most-recent trade in Outlook Therapeutics Inc is the sale of 0 shares on November 23, 2016, which brought Donald J. Griffith around $4.

Insider Trading History of Donald J. Griffith

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Donald J. Griffith Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Donald J. Griffith Ownership Network

Ownership Network List of Donald J. Griffith

No Data

Ownership Network Relation of Donald J. Griffith

Insider Network Chart

Donald J. Griffith Owned Company Details

What does Sonnet BioTherapeutics Holdings Inc do?

Who are the key executives at Sonnet BioTherapeutics Holdings Inc?

Donald J. Griffith is the director of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .

Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary

Over the past 18 months, Donald J. Griffith made no insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN). Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 371,600 shares made by Pankaj Mohan , a net purchase of 25,000 shares made by Nailesh Bhatt , and a net purchase of 23,255 shares made by Albert D. Dyrness .

In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 2,442 shares were bought by its insiders, resulting in a net purchase of 2,442 shares.

Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sonnet BioTherapeutics Holdings Inc Insider Transactions

No Available Data

Donald J. Griffith Mailing Address

Above is the net worth, insider trading, and ownership report for Donald J. Griffith. You might contact Donald J. Griffith via mailing address: C/o Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Princeton Nj 08540.